Document is current
Any future updates will be listed below
-
Authors
van Winkel, Claudia A. J. https://orcid.org/0009-0000-2579-7851
Pierik, Frank R. https://orcid.org/0000-0002-7304-4173
Brouwers, Adrienne H. https://orcid.org/0000-0003-2698-1516
de Groot, Derk Jan A. https://orcid.org/0000-0002-8306-6835
de Vries, Elisabeth G. E. https://orcid.org/0000-0002-8949-7425
Lub-de Hooge, Marjolijn N. https://orcid.org/0000-0002-5390-2791
- License Information
-
More Information
Article History
Accepted: 11 September 2024
First Online: 26 September 2024
Competing interests
: D.J.A.d.G. declares that he received institutional financial support for clinical trials or contracted research from Amgen, Bayer, GE Healthcare, Hoffmann La Roche and Siemens. E.G.E.d.V. declares that she received institutional financial support for acting as a member of advisory boards or consultancy services from Crescendo Biologics, Daiichi Sankyo and NSABP, as well as institutional financial support for clinical trials or contracted research grants from Amgen, Bayer, Crescendo Biologics, Genentech, Regeneron, Roche and Servier. M.N.L.-d.H. declares that she received institutional financial support for acting as a member of advisory boards or consultancy services from Merck and institutional financial support for conducting clinical and preclinical studies from Amgen, Bayer and Servier. The other authors declare no competing interests.
